In xenografts of NSG mice transplanted with EPHB4+ primary AML cells, targeting EPHB4 using the monoclonal antibody MAb131 markedly improved survival, particularly in combination with cytarabine (Merchant et al., 2017). The gene discussed is EPHB4; the disease is acute myeloid leukemia.